Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Тромбоз мозговых вен: от факторов риска до реканализации и клинических исходов
Тромбоз мозговых вен: от факторов риска до реканализации и клинических исходов
Батенькова Т.Ю. Тромбоз мозговых вен: от факторов риска до реканализации и клинических исходов. Consilium Medicum. 2024;26(2):117–124. DOI: 10.26442/20751753.2024.2.202603
© ООО «КОНСИЛИУМ МЕДИКУМ», 2024 г.
© ООО «КОНСИЛИУМ МЕДИКУМ», 2024 г.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Тромбоз мозговых вен, или церебральный венозный тромбоз (ЦВТ) – это редкое цереброваскулярное заболевание и неспецифический тип инсульта, на долю которого приходится 0,5–1% всех случаев инсульта. ЦВТ чаще встречается у женщин, чем у мужчин. Это связано с наличием таких факторов риска, как беременность, послеродовой период и использование оральных контрацептивов. Клинические симптомы возникают в результате повышения внутричерепного давления, вызванного нарушением венозного оттока и повреждением головного мозга. ЦВТ связан с широким спектром клинических симптомов от изолированных головных болей (наиболее частый симптом при поступлении, регистрируемый в 90% случаев) до фокальных дефицитов, судорог и изменений психического статуса. Диагноз ЦВТ считается одним из самых ошибочно диагностируемых в клинической неврологии, поскольку его гетерогенное проявление может быть как у молодых, так и у пожилых людей. Тщательный сбор анамнеза с прицельным выявлением факторов риска, проведение полноценной диагностики и лечения способствуют достижению благоприятного клинического исхода у пациентов. Акцент в статье сделан на степени реканализации ЦВТ, оценке венозных коллатералей по степени Qureshi и клинических исходах в зависимости от факторов риска. Эти показатели мало изучены в настоящее время.
Ключевые слова: тромбоз мозговых вен, реканализация, лечение, рецидив, клинические исходы
Keywords: cerebral vein thrombosis, recanalization, treatment, relapse, clinical outcomes
Ключевые слова: тромбоз мозговых вен, реканализация, лечение, рецидив, клинические исходы
________________________________________________
Keywords: cerebral vein thrombosis, recanalization, treatment, relapse, clinical outcomes
Полный текст
Список литературы
1. Medicherla CB, Pauley RA, de Havenon A, et al. Cerebral Venous Sinus Thrombosis in the COVID-19 Pandemic. J Neuroophthalmol. 2020;40(4):457-62. DOI:10.1097/WNO.0000000000001122
2. Amalia L. D-Dimer Level Associated with Amount of Sinus involvement Using Digital Subtraction Angiography on Cerebral Venous Thrombosis Patients. J Blood Med.
2023;14:303-8. DOI:10.2147/JBM.S399661
3. Theologou R, Nteveros A, Artemiadis A, Faropoulos K. Rare Causes of Cerebral Venus Sinus Thrombosis: A Systematic Review. Life. 2023;13(5):1178. DOI:10.3390/life13051178
4. Canedo-Antelo M, Baleato-González S, Mosqueira AJ, et al. Radiologic Clues to Cerebral Venous Thrombosis. Radiographics. 2019;39(6):1611-28. DOI:10.1148/rg.2019190015
5. Wei H, Jiang H, Zhou Y, et al. Intracranial hypertension after cerebral venous thrombosis–Risk factors and outcomes. CNS Neurosci Ther. 2023;29(9):2540-7. DOI:10.1111/cns.14194
6. Fan Y, Yu J, Chen H, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis. Stroke Vasc Neurol. 2020;5(2):152-8. DOI:10.1136/svn-2020-000358
7. Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555-65. DOI:10.1038/nrneurol.2017.104
8. Zenobia E, Lailiyya N, Dian S, et al. Platelet Selectin Levels in Patients with Cerebral Venous Sinus Thrombosis: Preliminary Findings. J Blood Med. 2023;14:359-65. DOI:10.2147/JBM.S405975
9. Sader N, de Lotbinière-Bassett M, Tso MK, Hamilton M. Management of Venous Sinus Thrombosis. Neurosurg Clin N Am. 2018;29(4):585-94. DOI:10.1016/j.nec.2018.06.011
10. Ulivi L, Squitieri M, Cohen H, et al. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020;20(5):356-67. DOI:10.1136/practneurol-2019-002415
11. Zuurbier SM, Hiltunen S, Tatlisumak T, et al. Admission Hyperglycemia and Clinical Outcome in Cerebral Venous Thrombosis. Stroke. 2016;47(2):390-6. DOI:10.1161/STROKEAHA.115.011177
12. Hung SH, Lin HC, Chung SD. Association between venous thromboembolism and iron-deficiency anemia: a population-based study. Blood Coagul Fibrinolysis.
2015;26(4):368-72. DOI:10.1097/MBC.0000000000000249
13. Liu K, Song B, Gao Y, et al. Long-Term Outcomes in Patients with Anemia And Cerebral Venous Thrombosis. Neurocrit Care. 2018;29(3):463-8. DOI:10.1007/s12028-018-0544-6
14. Azizi N, Maghbooli M, Rostami M, Kian S. Serum Levels of Ferritin, Iron, and TIBC in Cerebral Venous Sinus Thrombosis. Arch Neurosci. 2023;10(2). DOI:10.5812/ans-134857
15. Barboza MA, Mejias C, Colin-Luna J, et al. Intracranial venous collaterals in cerebral venous thrombosis: clinical and imaging impact. J Neurol Neurosurg Psychiatry. 2015;86(12):1314-8. DOI:10.1136/jnnp-2014-309717
16. Song S, Lan D, Wu XQ, Meng R. The clinical characteristic, diagnosis, treatment, and prognosis of cerebral cortical vein thrombosis: a systematic review of 325 cases. J Thromb Thrombolysis. 2021;51(3):734-40. DOI:10.1007/s11239-020-02229-x
17. Duman T, Uluduz D, Midi I, et al. A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study. J Stroke Cerebrovasc Dis.
2017;26(8):1848-57. DOI:10.1016/j.jstrokecerebrovasdis.2017.04.020
18. Lindgren E, Krzywicka K, de Winter MA, et al. A scoring tool to predict mortality and dependency after cerebral venous thrombosis. Eur J Neurol. 2023;30(8):2305-14.. DOI:10.1111/ene.15844
19. Begley SL, White TG, Katz JM. Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy. Curr Treat Options Neurol. 2023;25(8):1-17.
DOI:10.1007/s11940-023-00752-9
20. Huang P. Rare cause of cerebral venous sinus thrombosis: Spontaneous intracranial hypotension syndrome: A case report. World J Clin Cases. 2023;11(19):4677-83. DOI:10.12998/wjcc.v11.i19.4677
21. Chen YC, Chang CW, Wu HC, et al. Clinical Characteristics and Prognostic Factors of Non-Infectious Cerebral Venous Sinus Thrombosis. J Clin Med. 2022;11(20):6096. DOI:10.3390/jcm11206096
22. Pasricha SV, Bhayana R, Wu PE. Supine headache and papilledema: A case and review of cerebral venous sinus thrombosis. Clin Case Rep. 2023;11(5):e07329. DOI:10.1002/ccr3.7329
23. Pongmoragot J, Saposnik G. Intracerebral Hemorrhage from Cerebral Venous Thrombosis. Curr Atheroscler Rep. 2012;14(4):382-9. DOI:10.1007/s11883-012-0260-1
24. Coutinho JM, Zuurbier SM, Stam J. Declining Mortality in Cerebral Venous Thrombosis: A Systematic Review. Stroke. 2014;45(5):1338-41. DOI:10.1161/STROKEAHA.113.004666
25. Sachdeva V, Nalawade R, Kannam M, et al. Clinical profile, diagnostic challenges, and outcomes in subacute/chronic cerebral sinus venous thrombosis. Indian J Ophthalmol. 2021;69(12):3598. DOI:10.4103/ijo.IJO_96_21
26. Afifi K, Bellanger G, Buyck PJ, et al. Features of intracranial hemorrhage in cerebral venous thrombosis. J Neurol. 2020;267(11):3292-8. DOI:10.1007/s00415-020-10008-0
27. Kumral E, Polat F, Uzunköprü C, et al. The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non-hemorrhagic infarct, and non-lesional venous stroke in patients with cerebral sinus-venous thrombosis: The clinical/neuroradiological spectrum of cerebral sinus-vein thrombosis. Eur J Neurol. 2012;19(4):537-43. DOI:10.1111/j.1468-1331.2011.03562.x
28. Mahale R, Mehta A, John AA, et al. Acute seizures in cerebral venous sinus thrombosis: What predicts it? Epilepsy Res. 2016;123:1-5. DOI:10.1016/j.eplepsyres.2016.01.011
29. Uluduz D, Midi I, Duman T, et al. Epileptic seizures in cerebral venous sinus thrombosis: Subgroup analysis of VENOST study. Seizure. 2020;78:113-7. DOI:10.1016/j.seizure.2020.02.017
30. Ferro JM, Canhão P, Bousser MG, et al. Early Seizures in Cerebral Vein and Dural Sinus Thrombosis: Risk Factors and Role of Antiepileptics. Stroke.
2008;39(4):1152-8. DOI:10.1161/STROKEAHA.107.487363
31. García-Azorín D, Monje MHG, González-García N, et al. Presence of red flags in patients with cerebral venous sinus thrombosis admitted to the emergency department because of headache: A STROBE compliant cohort-study. Medicine (Baltimore). 2020;99(29):e20900. DOI:10.1097/MD.0000000000020900
32. Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – Endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195-221. DOI:10.1177/2396987317719364
33. Kharbat AF, Michel M, Morgan R, et al. Intracranial venous sinus thrombosis: Medical and surgical management considerations. BOHR Int J Neurol Neurosci.
2023;1(2):60-71. DOI:10.54646/bijnn.2023.09
34. Herweh C, Griebe M, Geisbüsch C, et al. Frequency and temporal profile of recanalization after cerebral vein and sinus thrombosis. Eur J Neurol. 2016;23(4):681-7. DOI:10.1111/ene.12901
35. Alimohammadi A, Kim DJ, Field TS. Updates in cerebral venous thrombosis. Curr Cardiol Rep. 2022;24(1):43-50. DOI:10.1007/s11886-021-01622-z
36. Wasay M, Khan M, Rajput HM, et al. New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study. J Stroke.
2019;21(2):220-3. DOI:10.5853/jos.2019.00150
37. Li H, Yao M, Liao S, et al. Comparison of Novel Oral Anticoagulants and Vitamin K Antagonists in Patients With Cerebral Venous Sinus Thrombosis on Efficacy and Safety: A Systematic Review. Front Neurol. 2020;11:597623. DOI:10.3389/fneur.2020.597623
38. Lee GKH, Chen VH, Tan CH, et al. Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis. J Thromb Thrombolysis. 2020;50(3):724-31. DOI:10.1007/s11239-020-02106-7
39. Nepal G, Kharel S, Bhagat R, et al. Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta-analysis. Acta Neurol Scand. 2022;145(1):10-23. DOI:10.1111/ane.13506
40. Esmaeili S, Abolmaali M, Aarabi S, et al. Rivaroxaban for the treatment of cerebral venous thrombosis. BMC Neurol. 2021;21(1):73. DOI:10.1186/s12883-021-02091-1
41. Maqsood M, Imran Hasan Khan M, Yameen M, et al. Use of oral rivaroxaban in cerebral venous thrombosis. J Drug Assess. 2021;10(1):1-6. DOI:10.1080/21556660.2020.1838769
42. Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis.
2019;78(10):1296-304. DOI:10.1136/annrheumdis-2019-215213
43. Dubey AK, Kalita J, Chaudhary SK, Misra UK. Impact of anticoagulation status on recanalization and outcome of cerebral venous thrombosis. J Clin Neurosci. 2021;89:43-50. DOI:10.1016/j.jocn.2021.04.016
44. Gazioglu S, Eyuboglu I, Yildirim A, et al. Cerebral venous sinus Thrombosis: Clinical Features, Long-Term outcome and recanalization. J Clin Neurosci. 2017;45:248-51. DOI:10.1016/j.jocn.2017.07.028
45. Zhao Y, Su X, Liu Z, et al. Effect of intracranial venous collaterals on neurological outcomes in cerebral venous thrombosis. J Clin Neurosci. 2022;102:95-100. DOI:10.1016/j.jocn.2022.06.009
46. Ferro JM, Canhão P, Stam J, et al. Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664-70. DOI:10.1161/01.STR.0000117571.76197.26
47. Ilyas A, Chen CJ, Raper DM, et al. Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: a systematic review. J NeuroInterventional Surg.
2017;9(11):1086-92. DOI:10.1136/neurintsurg-2016-012938
48. Klein P, Shu L, Nguyen TN, et al. Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score. J Stroke. 2022;24(3):404-16. DOI:10.5853/jos.2022.01606
49. Liu L, Jiang H, Wei H, et al. Risk factors of impaired employability after cerebral venous thrombosis. CNS Neurosci Ther. 2023;29(4):1086-93. DOI:10.1111/cns.14083
50. Rezoagli E, Martinelli I, Poli D, et al. The effect of recanalization on long-term neurological outcome after cerebral venous thrombosis. J Thromb Haemost. 2018;16(4):718-24. DOI:10.1111/jth.13954
51. Shakibajahromi B, Haghighi AB, Salehi A, et al. Clinical and radiological characteristics and predictors of outcome of cerebral venous sinus thrombosis, a hospital-based study. Acta Neurol Belg. 2020;120(4):845-52. DOI:10.1007/s13760-018-1009-6
52. Zhang Y, Liu Y, Qin B, et al. Characteristics of Poor Prognosis in Patients with Cerebral Venous Sinus Thrombosis: A Multicenter Retrospective Study. Neuropsychiatr Dis Treat. 2023;19:1417-26. DOI:10.2147/NDT.S414123
53. Aguiar de Sousa D, Lucas Neto L, Arauz A, et al. Early Recanalization in Patients With Cerebral Venous Thrombosis Treated With Anticoagulation. Stroke.
2020;51(4):1174-81. DOI:10.1161/STROKEAHA.119.028532
54. Aguiar de Sousa D, Lucas Neto L, Canhão P, Ferro JM. Recanalization in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis. Stroke.
2018;49(8):1828-35. DOI:10.1161/STROKEAHA.118.022129
55. Arauz A, Vargas-González JC, Arguelles-Morales N, et al. Time to recanalisation in patients with cerebral venous thrombosis under anticoagulation therapy. J Neurol Neurosurg Psychiatry. 2016;87(3):247-51. DOI:10.1136/jnnp-2014-310068
56. Karthik Vanukuri N, Pedapati R, Shanmugam S, et al. Effect of recanalization on clinical outcomes in patients with cerebral venous thrombosis – An ambispective study. Eur J Radiol. 2022;153:110385. DOI:10.1016/j.ejrad.2022.110385
57. Nagaraja D. Recanalisation and outcome in cerebral venous-sinus thrombosis. Ann Indian Acad Neurol. 2022;25(2):177. DOI:10.4103/aian.aian_957_21
58. Putaala J, Hiltunen S, Salonen O, et al. Recanalization and its correlation to outcome after cerebral venous thrombosis. J Neurol Sci. 2010;292(1-2):11-5. DOI:10.1016/j.jns.2010.02.017
59. Ferro JM, Aguiar de Sousa D. Cerebral Venous Thrombosis: an Update. Curr Neurol Neurosci Rep. 2019;19(10):74. DOI:10.1007/s11910-019-0988-x
60. Triquenot Bagan A, Crassard I, Drouet L, et al. Cerebral Venous Thrombosis: Clinical, Radiological, Biological, and Etiological Characteristics of a French Prospective Cohort (FPCCVT)–Comparison with ISCVT Cohort. Front Neurol. 2021;12:753110. DOI:10.3389/fneur.2021.753110
61. Yaghi S, Shu L, Bakradze E, et al. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. Stroke. 2022;53(3):728-38. DOI:10.1161/STROKEAHA.121.037541
62. Green M, Styles T, Russell T, et al. Non-genetic and genetic risk factors for adult cerebral venous thrombosis. Thromb Res. 2018;169:15-22. DOI:10.1016/j.thromres.2018.07.005
2. Amalia L. D-Dimer Level Associated with Amount of Sinus involvement Using Digital Subtraction Angiography on Cerebral Venous Thrombosis Patients. J Blood Med.
2023;14:303-8. DOI:10.2147/JBM.S399661
3. Theologou R, Nteveros A, Artemiadis A, Faropoulos K. Rare Causes of Cerebral Venus Sinus Thrombosis: A Systematic Review. Life. 2023;13(5):1178. DOI:10.3390/life13051178
4. Canedo-Antelo M, Baleato-González S, Mosqueira AJ, et al. Radiologic Clues to Cerebral Venous Thrombosis. Radiographics. 2019;39(6):1611-28. DOI:10.1148/rg.2019190015
5. Wei H, Jiang H, Zhou Y, et al. Intracranial hypertension after cerebral venous thrombosis–Risk factors and outcomes. CNS Neurosci Ther. 2023;29(9):2540-7. DOI:10.1111/cns.14194
6. Fan Y, Yu J, Chen H, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis. Stroke Vasc Neurol. 2020;5(2):152-8. DOI:10.1136/svn-2020-000358
7. Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555-65. DOI:10.1038/nrneurol.2017.104
8. Zenobia E, Lailiyya N, Dian S, et al. Platelet Selectin Levels in Patients with Cerebral Venous Sinus Thrombosis: Preliminary Findings. J Blood Med. 2023;14:359-65. DOI:10.2147/JBM.S405975
9. Sader N, de Lotbinière-Bassett M, Tso MK, Hamilton M. Management of Venous Sinus Thrombosis. Neurosurg Clin N Am. 2018;29(4):585-94. DOI:10.1016/j.nec.2018.06.011
10. Ulivi L, Squitieri M, Cohen H, et al. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020;20(5):356-67. DOI:10.1136/practneurol-2019-002415
11. Zuurbier SM, Hiltunen S, Tatlisumak T, et al. Admission Hyperglycemia and Clinical Outcome in Cerebral Venous Thrombosis. Stroke. 2016;47(2):390-6. DOI:10.1161/STROKEAHA.115.011177
12. Hung SH, Lin HC, Chung SD. Association between venous thromboembolism and iron-deficiency anemia: a population-based study. Blood Coagul Fibrinolysis.
2015;26(4):368-72. DOI:10.1097/MBC.0000000000000249
13. Liu K, Song B, Gao Y, et al. Long-Term Outcomes in Patients with Anemia And Cerebral Venous Thrombosis. Neurocrit Care. 2018;29(3):463-8. DOI:10.1007/s12028-018-0544-6
14. Azizi N, Maghbooli M, Rostami M, Kian S. Serum Levels of Ferritin, Iron, and TIBC in Cerebral Venous Sinus Thrombosis. Arch Neurosci. 2023;10(2). DOI:10.5812/ans-134857
15. Barboza MA, Mejias C, Colin-Luna J, et al. Intracranial venous collaterals in cerebral venous thrombosis: clinical and imaging impact. J Neurol Neurosurg Psychiatry. 2015;86(12):1314-8. DOI:10.1136/jnnp-2014-309717
16. Song S, Lan D, Wu XQ, Meng R. The clinical characteristic, diagnosis, treatment, and prognosis of cerebral cortical vein thrombosis: a systematic review of 325 cases. J Thromb Thrombolysis. 2021;51(3):734-40. DOI:10.1007/s11239-020-02229-x
17. Duman T, Uluduz D, Midi I, et al. A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study. J Stroke Cerebrovasc Dis.
2017;26(8):1848-57. DOI:10.1016/j.jstrokecerebrovasdis.2017.04.020
18. Lindgren E, Krzywicka K, de Winter MA, et al. A scoring tool to predict mortality and dependency after cerebral venous thrombosis. Eur J Neurol. 2023;30(8):2305-14.. DOI:10.1111/ene.15844
19. Begley SL, White TG, Katz JM. Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy. Curr Treat Options Neurol. 2023;25(8):1-17.
DOI:10.1007/s11940-023-00752-9
20. Huang P. Rare cause of cerebral venous sinus thrombosis: Spontaneous intracranial hypotension syndrome: A case report. World J Clin Cases. 2023;11(19):4677-83. DOI:10.12998/wjcc.v11.i19.4677
21. Chen YC, Chang CW, Wu HC, et al. Clinical Characteristics and Prognostic Factors of Non-Infectious Cerebral Venous Sinus Thrombosis. J Clin Med. 2022;11(20):6096. DOI:10.3390/jcm11206096
22. Pasricha SV, Bhayana R, Wu PE. Supine headache and papilledema: A case and review of cerebral venous sinus thrombosis. Clin Case Rep. 2023;11(5):e07329. DOI:10.1002/ccr3.7329
23. Pongmoragot J, Saposnik G. Intracerebral Hemorrhage from Cerebral Venous Thrombosis. Curr Atheroscler Rep. 2012;14(4):382-9. DOI:10.1007/s11883-012-0260-1
24. Coutinho JM, Zuurbier SM, Stam J. Declining Mortality in Cerebral Venous Thrombosis: A Systematic Review. Stroke. 2014;45(5):1338-41. DOI:10.1161/STROKEAHA.113.004666
25. Sachdeva V, Nalawade R, Kannam M, et al. Clinical profile, diagnostic challenges, and outcomes in subacute/chronic cerebral sinus venous thrombosis. Indian J Ophthalmol. 2021;69(12):3598. DOI:10.4103/ijo.IJO_96_21
26. Afifi K, Bellanger G, Buyck PJ, et al. Features of intracranial hemorrhage in cerebral venous thrombosis. J Neurol. 2020;267(11):3292-8. DOI:10.1007/s00415-020-10008-0
27. Kumral E, Polat F, Uzunköprü C, et al. The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non-hemorrhagic infarct, and non-lesional venous stroke in patients with cerebral sinus-venous thrombosis: The clinical/neuroradiological spectrum of cerebral sinus-vein thrombosis. Eur J Neurol. 2012;19(4):537-43. DOI:10.1111/j.1468-1331.2011.03562.x
28. Mahale R, Mehta A, John AA, et al. Acute seizures in cerebral venous sinus thrombosis: What predicts it? Epilepsy Res. 2016;123:1-5. DOI:10.1016/j.eplepsyres.2016.01.011
29. Uluduz D, Midi I, Duman T, et al. Epileptic seizures in cerebral venous sinus thrombosis: Subgroup analysis of VENOST study. Seizure. 2020;78:113-7. DOI:10.1016/j.seizure.2020.02.017
30. Ferro JM, Canhão P, Bousser MG, et al. Early Seizures in Cerebral Vein and Dural Sinus Thrombosis: Risk Factors and Role of Antiepileptics. Stroke.
2008;39(4):1152-8. DOI:10.1161/STROKEAHA.107.487363
31. García-Azorín D, Monje MHG, González-García N, et al. Presence of red flags in patients with cerebral venous sinus thrombosis admitted to the emergency department because of headache: A STROBE compliant cohort-study. Medicine (Baltimore). 2020;99(29):e20900. DOI:10.1097/MD.0000000000020900
32. Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – Endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195-221. DOI:10.1177/2396987317719364
33. Kharbat AF, Michel M, Morgan R, et al. Intracranial venous sinus thrombosis: Medical and surgical management considerations. BOHR Int J Neurol Neurosci.
2023;1(2):60-71. DOI:10.54646/bijnn.2023.09
34. Herweh C, Griebe M, Geisbüsch C, et al. Frequency and temporal profile of recanalization after cerebral vein and sinus thrombosis. Eur J Neurol. 2016;23(4):681-7. DOI:10.1111/ene.12901
35. Alimohammadi A, Kim DJ, Field TS. Updates in cerebral venous thrombosis. Curr Cardiol Rep. 2022;24(1):43-50. DOI:10.1007/s11886-021-01622-z
36. Wasay M, Khan M, Rajput HM, et al. New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study. J Stroke.
2019;21(2):220-3. DOI:10.5853/jos.2019.00150
37. Li H, Yao M, Liao S, et al. Comparison of Novel Oral Anticoagulants and Vitamin K Antagonists in Patients With Cerebral Venous Sinus Thrombosis on Efficacy and Safety: A Systematic Review. Front Neurol. 2020;11:597623. DOI:10.3389/fneur.2020.597623
38. Lee GKH, Chen VH, Tan CH, et al. Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis. J Thromb Thrombolysis. 2020;50(3):724-31. DOI:10.1007/s11239-020-02106-7
39. Nepal G, Kharel S, Bhagat R, et al. Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta-analysis. Acta Neurol Scand. 2022;145(1):10-23. DOI:10.1111/ane.13506
40. Esmaeili S, Abolmaali M, Aarabi S, et al. Rivaroxaban for the treatment of cerebral venous thrombosis. BMC Neurol. 2021;21(1):73. DOI:10.1186/s12883-021-02091-1
41. Maqsood M, Imran Hasan Khan M, Yameen M, et al. Use of oral rivaroxaban in cerebral venous thrombosis. J Drug Assess. 2021;10(1):1-6. DOI:10.1080/21556660.2020.1838769
42. Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis.
2019;78(10):1296-304. DOI:10.1136/annrheumdis-2019-215213
43. Dubey AK, Kalita J, Chaudhary SK, Misra UK. Impact of anticoagulation status on recanalization and outcome of cerebral venous thrombosis. J Clin Neurosci. 2021;89:43-50. DOI:10.1016/j.jocn.2021.04.016
44. Gazioglu S, Eyuboglu I, Yildirim A, et al. Cerebral venous sinus Thrombosis: Clinical Features, Long-Term outcome and recanalization. J Clin Neurosci. 2017;45:248-51. DOI:10.1016/j.jocn.2017.07.028
45. Zhao Y, Su X, Liu Z, et al. Effect of intracranial venous collaterals on neurological outcomes in cerebral venous thrombosis. J Clin Neurosci. 2022;102:95-100. DOI:10.1016/j.jocn.2022.06.009
46. Ferro JM, Canhão P, Stam J, et al. Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664-70. DOI:10.1161/01.STR.0000117571.76197.26
47. Ilyas A, Chen CJ, Raper DM, et al. Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: a systematic review. J NeuroInterventional Surg.
2017;9(11):1086-92. DOI:10.1136/neurintsurg-2016-012938
48. Klein P, Shu L, Nguyen TN, et al. Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score. J Stroke. 2022;24(3):404-16. DOI:10.5853/jos.2022.01606
49. Liu L, Jiang H, Wei H, et al. Risk factors of impaired employability after cerebral venous thrombosis. CNS Neurosci Ther. 2023;29(4):1086-93. DOI:10.1111/cns.14083
50. Rezoagli E, Martinelli I, Poli D, et al. The effect of recanalization on long-term neurological outcome after cerebral venous thrombosis. J Thromb Haemost. 2018;16(4):718-24. DOI:10.1111/jth.13954
51. Shakibajahromi B, Haghighi AB, Salehi A, et al. Clinical and radiological characteristics and predictors of outcome of cerebral venous sinus thrombosis, a hospital-based study. Acta Neurol Belg. 2020;120(4):845-52. DOI:10.1007/s13760-018-1009-6
52. Zhang Y, Liu Y, Qin B, et al. Characteristics of Poor Prognosis in Patients with Cerebral Venous Sinus Thrombosis: A Multicenter Retrospective Study. Neuropsychiatr Dis Treat. 2023;19:1417-26. DOI:10.2147/NDT.S414123
53. Aguiar de Sousa D, Lucas Neto L, Arauz A, et al. Early Recanalization in Patients With Cerebral Venous Thrombosis Treated With Anticoagulation. Stroke.
2020;51(4):1174-81. DOI:10.1161/STROKEAHA.119.028532
54. Aguiar de Sousa D, Lucas Neto L, Canhão P, Ferro JM. Recanalization in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis. Stroke.
2018;49(8):1828-35. DOI:10.1161/STROKEAHA.118.022129
55. Arauz A, Vargas-González JC, Arguelles-Morales N, et al. Time to recanalisation in patients with cerebral venous thrombosis under anticoagulation therapy. J Neurol Neurosurg Psychiatry. 2016;87(3):247-51. DOI:10.1136/jnnp-2014-310068
56. Karthik Vanukuri N, Pedapati R, Shanmugam S, et al. Effect of recanalization on clinical outcomes in patients with cerebral venous thrombosis – An ambispective study. Eur J Radiol. 2022;153:110385. DOI:10.1016/j.ejrad.2022.110385
57. Nagaraja D. Recanalisation and outcome in cerebral venous-sinus thrombosis. Ann Indian Acad Neurol. 2022;25(2):177. DOI:10.4103/aian.aian_957_21
58. Putaala J, Hiltunen S, Salonen O, et al. Recanalization and its correlation to outcome after cerebral venous thrombosis. J Neurol Sci. 2010;292(1-2):11-5. DOI:10.1016/j.jns.2010.02.017
59. Ferro JM, Aguiar de Sousa D. Cerebral Venous Thrombosis: an Update. Curr Neurol Neurosci Rep. 2019;19(10):74. DOI:10.1007/s11910-019-0988-x
60. Triquenot Bagan A, Crassard I, Drouet L, et al. Cerebral Venous Thrombosis: Clinical, Radiological, Biological, and Etiological Characteristics of a French Prospective Cohort (FPCCVT)–Comparison with ISCVT Cohort. Front Neurol. 2021;12:753110. DOI:10.3389/fneur.2021.753110
61. Yaghi S, Shu L, Bakradze E, et al. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. Stroke. 2022;53(3):728-38. DOI:10.1161/STROKEAHA.121.037541
62. Green M, Styles T, Russell T, et al. Non-genetic and genetic risk factors for adult cerebral venous thrombosis. Thromb Res. 2018;169:15-22. DOI:10.1016/j.thromres.2018.07.005
2. Amalia L. D-Dimer Level Associated with Amount of Sinus involvement Using Digital Subtraction Angiography on Cerebral Venous Thrombosis Patients. J Blood Med.
2023;14:303-8. DOI:10.2147/JBM.S399661
3. Theologou R, Nteveros A, Artemiadis A, Faropoulos K. Rare Causes of Cerebral Venus Sinus Thrombosis: A Systematic Review. Life. 2023;13(5):1178. DOI:10.3390/life13051178
4. Canedo-Antelo M, Baleato-González S, Mosqueira AJ, et al. Radiologic Clues to Cerebral Venous Thrombosis. Radiographics. 2019;39(6):1611-28. DOI:10.1148/rg.2019190015
5. Wei H, Jiang H, Zhou Y, et al. Intracranial hypertension after cerebral venous thrombosis–Risk factors and outcomes. CNS Neurosci Ther. 2023;29(9):2540-7. DOI:10.1111/cns.14194
6. Fan Y, Yu J, Chen H, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis. Stroke Vasc Neurol. 2020;5(2):152-8. DOI:10.1136/svn-2020-000358
7. Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555-65. DOI:10.1038/nrneurol.2017.104
8. Zenobia E, Lailiyya N, Dian S, et al. Platelet Selectin Levels in Patients with Cerebral Venous Sinus Thrombosis: Preliminary Findings. J Blood Med. 2023;14:359-65. DOI:10.2147/JBM.S405975
9. Sader N, de Lotbinière-Bassett M, Tso MK, Hamilton M. Management of Venous Sinus Thrombosis. Neurosurg Clin N Am. 2018;29(4):585-94. DOI:10.1016/j.nec.2018.06.011
10. Ulivi L, Squitieri M, Cohen H, et al. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020;20(5):356-67. DOI:10.1136/practneurol-2019-002415
11. Zuurbier SM, Hiltunen S, Tatlisumak T, et al. Admission Hyperglycemia and Clinical Outcome in Cerebral Venous Thrombosis. Stroke. 2016;47(2):390-6. DOI:10.1161/STROKEAHA.115.011177
12. Hung SH, Lin HC, Chung SD. Association between venous thromboembolism and iron-deficiency anemia: a population-based study. Blood Coagul Fibrinolysis.
2015;26(4):368-72. DOI:10.1097/MBC.0000000000000249
13. Liu K, Song B, Gao Y, et al. Long-Term Outcomes in Patients with Anemia And Cerebral Venous Thrombosis. Neurocrit Care. 2018;29(3):463-8. DOI:10.1007/s12028-018-0544-6
14. Azizi N, Maghbooli M, Rostami M, Kian S. Serum Levels of Ferritin, Iron, and TIBC in Cerebral Venous Sinus Thrombosis. Arch Neurosci. 2023;10(2). DOI:10.5812/ans-134857
15. Barboza MA, Mejias C, Colin-Luna J, et al. Intracranial venous collaterals in cerebral venous thrombosis: clinical and imaging impact. J Neurol Neurosurg Psychiatry. 2015;86(12):1314-8. DOI:10.1136/jnnp-2014-309717
16. Song S, Lan D, Wu XQ, Meng R. The clinical characteristic, diagnosis, treatment, and prognosis of cerebral cortical vein thrombosis: a systematic review of 325 cases. J Thromb Thrombolysis. 2021;51(3):734-40. DOI:10.1007/s11239-020-02229-x
17. Duman T, Uluduz D, Midi I, et al. A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study. J Stroke Cerebrovasc Dis.
2017;26(8):1848-57. DOI:10.1016/j.jstrokecerebrovasdis.2017.04.020
18. Lindgren E, Krzywicka K, de Winter MA, et al. A scoring tool to predict mortality and dependency after cerebral venous thrombosis. Eur J Neurol. 2023;30(8):2305-14.. DOI:10.1111/ene.15844
19. Begley SL, White TG, Katz JM. Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy. Curr Treat Options Neurol. 2023;25(8):1-17.
DOI:10.1007/s11940-023-00752-9
20. Huang P. Rare cause of cerebral venous sinus thrombosis: Spontaneous intracranial hypotension syndrome: A case report. World J Clin Cases. 2023;11(19):4677-83. DOI:10.12998/wjcc.v11.i19.4677
21. Chen YC, Chang CW, Wu HC, et al. Clinical Characteristics and Prognostic Factors of Non-Infectious Cerebral Venous Sinus Thrombosis. J Clin Med. 2022;11(20):6096. DOI:10.3390/jcm11206096
22. Pasricha SV, Bhayana R, Wu PE. Supine headache and papilledema: A case and review of cerebral venous sinus thrombosis. Clin Case Rep. 2023;11(5):e07329. DOI:10.1002/ccr3.7329
23. Pongmoragot J, Saposnik G. Intracerebral Hemorrhage from Cerebral Venous Thrombosis. Curr Atheroscler Rep. 2012;14(4):382-9. DOI:10.1007/s11883-012-0260-1
24. Coutinho JM, Zuurbier SM, Stam J. Declining Mortality in Cerebral Venous Thrombosis: A Systematic Review. Stroke. 2014;45(5):1338-41. DOI:10.1161/STROKEAHA.113.004666
25. Sachdeva V, Nalawade R, Kannam M, et al. Clinical profile, diagnostic challenges, and outcomes in subacute/chronic cerebral sinus venous thrombosis. Indian J Ophthalmol. 2021;69(12):3598. DOI:10.4103/ijo.IJO_96_21
26. Afifi K, Bellanger G, Buyck PJ, et al. Features of intracranial hemorrhage in cerebral venous thrombosis. J Neurol. 2020;267(11):3292-8. DOI:10.1007/s00415-020-10008-0
27. Kumral E, Polat F, Uzunköprü C, et al. The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non-hemorrhagic infarct, and non-lesional venous stroke in patients with cerebral sinus-venous thrombosis: The clinical/neuroradiological spectrum of cerebral sinus-vein thrombosis. Eur J Neurol. 2012;19(4):537-43. DOI:10.1111/j.1468-1331.2011.03562.x
28. Mahale R, Mehta A, John AA, et al. Acute seizures in cerebral venous sinus thrombosis: What predicts it? Epilepsy Res. 2016;123:1-5. DOI:10.1016/j.eplepsyres.2016.01.011
29. Uluduz D, Midi I, Duman T, et al. Epileptic seizures in cerebral venous sinus thrombosis: Subgroup analysis of VENOST study. Seizure. 2020;78:113-7. DOI:10.1016/j.seizure.2020.02.017
30. Ferro JM, Canhão P, Bousser MG, et al. Early Seizures in Cerebral Vein and Dural Sinus Thrombosis: Risk Factors and Role of Antiepileptics. Stroke.
2008;39(4):1152-8. DOI:10.1161/STROKEAHA.107.487363
31. García-Azorín D, Monje MHG, González-García N, et al. Presence of red flags in patients with cerebral venous sinus thrombosis admitted to the emergency department because of headache: A STROBE compliant cohort-study. Medicine (Baltimore). 2020;99(29):e20900. DOI:10.1097/MD.0000000000020900
32. Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – Endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195-221. DOI:10.1177/2396987317719364
33. Kharbat AF, Michel M, Morgan R, et al. Intracranial venous sinus thrombosis: Medical and surgical management considerations. BOHR Int J Neurol Neurosci.
2023;1(2):60-71. DOI:10.54646/bijnn.2023.09
34. Herweh C, Griebe M, Geisbüsch C, et al. Frequency and temporal profile of recanalization after cerebral vein and sinus thrombosis. Eur J Neurol. 2016;23(4):681-7. DOI:10.1111/ene.12901
35. Alimohammadi A, Kim DJ, Field TS. Updates in cerebral venous thrombosis. Curr Cardiol Rep. 2022;24(1):43-50. DOI:10.1007/s11886-021-01622-z
36. Wasay M, Khan M, Rajput HM, et al. New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study. J Stroke.
2019;21(2):220-3. DOI:10.5853/jos.2019.00150
37. Li H, Yao M, Liao S, et al. Comparison of Novel Oral Anticoagulants and Vitamin K Antagonists in Patients With Cerebral Venous Sinus Thrombosis on Efficacy and Safety: A Systematic Review. Front Neurol. 2020;11:597623. DOI:10.3389/fneur.2020.597623
38. Lee GKH, Chen VH, Tan CH, et al. Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis. J Thromb Thrombolysis. 2020;50(3):724-31. DOI:10.1007/s11239-020-02106-7
39. Nepal G, Kharel S, Bhagat R, et al. Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta-analysis. Acta Neurol Scand. 2022;145(1):10-23. DOI:10.1111/ane.13506
40. Esmaeili S, Abolmaali M, Aarabi S, et al. Rivaroxaban for the treatment of cerebral venous thrombosis. BMC Neurol. 2021;21(1):73. DOI:10.1186/s12883-021-02091-1
41. Maqsood M, Imran Hasan Khan M, Yameen M, et al. Use of oral rivaroxaban in cerebral venous thrombosis. J Drug Assess. 2021;10(1):1-6. DOI:10.1080/21556660.2020.1838769
42. Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis.
2019;78(10):1296-304. DOI:10.1136/annrheumdis-2019-215213
43. Dubey AK, Kalita J, Chaudhary SK, Misra UK. Impact of anticoagulation status on recanalization and outcome of cerebral venous thrombosis. J Clin Neurosci. 2021;89:43-50. DOI:10.1016/j.jocn.2021.04.016
44. Gazioglu S, Eyuboglu I, Yildirim A, et al. Cerebral venous sinus Thrombosis: Clinical Features, Long-Term outcome and recanalization. J Clin Neurosci. 2017;45:248-51. DOI:10.1016/j.jocn.2017.07.028
45. Zhao Y, Su X, Liu Z, et al. Effect of intracranial venous collaterals on neurological outcomes in cerebral venous thrombosis. J Clin Neurosci. 2022;102:95-100. DOI:10.1016/j.jocn.2022.06.009
46. Ferro JM, Canhão P, Stam J, et al. Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664-70. DOI:10.1161/01.STR.0000117571.76197.26
47. Ilyas A, Chen CJ, Raper DM, et al. Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: a systematic review. J NeuroInterventional Surg.
2017;9(11):1086-92. DOI:10.1136/neurintsurg-2016-012938
48. Klein P, Shu L, Nguyen TN, et al. Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score. J Stroke. 2022;24(3):404-16. DOI:10.5853/jos.2022.01606
49. Liu L, Jiang H, Wei H, et al. Risk factors of impaired employability after cerebral venous thrombosis. CNS Neurosci Ther. 2023;29(4):1086-93. DOI:10.1111/cns.14083
50. Rezoagli E, Martinelli I, Poli D, et al. The effect of recanalization on long-term neurological outcome after cerebral venous thrombosis. J Thromb Haemost. 2018;16(4):718-24. DOI:10.1111/jth.13954
51. Shakibajahromi B, Haghighi AB, Salehi A, et al. Clinical and radiological characteristics and predictors of outcome of cerebral venous sinus thrombosis, a hospital-based study. Acta Neurol Belg. 2020;120(4):845-52. DOI:10.1007/s13760-018-1009-6
52. Zhang Y, Liu Y, Qin B, et al. Characteristics of Poor Prognosis in Patients with Cerebral Venous Sinus Thrombosis: A Multicenter Retrospective Study. Neuropsychiatr Dis Treat. 2023;19:1417-26. DOI:10.2147/NDT.S414123
53. Aguiar de Sousa D, Lucas Neto L, Arauz A, et al. Early Recanalization in Patients With Cerebral Venous Thrombosis Treated With Anticoagulation. Stroke.
2020;51(4):1174-81. DOI:10.1161/STROKEAHA.119.028532
54. Aguiar de Sousa D, Lucas Neto L, Canhão P, Ferro JM. Recanalization in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis. Stroke.
2018;49(8):1828-35. DOI:10.1161/STROKEAHA.118.022129
55. Arauz A, Vargas-González JC, Arguelles-Morales N, et al. Time to recanalisation in patients with cerebral venous thrombosis under anticoagulation therapy. J Neurol Neurosurg Psychiatry. 2016;87(3):247-51. DOI:10.1136/jnnp-2014-310068
56. Karthik Vanukuri N, Pedapati R, Shanmugam S, et al. Effect of recanalization on clinical outcomes in patients with cerebral venous thrombosis – An ambispective study. Eur J Radiol. 2022;153:110385. DOI:10.1016/j.ejrad.2022.110385
57. Nagaraja D. Recanalisation and outcome in cerebral venous-sinus thrombosis. Ann Indian Acad Neurol. 2022;25(2):177. DOI:10.4103/aian.aian_957_21
58. Putaala J, Hiltunen S, Salonen O, et al. Recanalization and its correlation to outcome after cerebral venous thrombosis. J Neurol Sci. 2010;292(1-2):11-5. DOI:10.1016/j.jns.2010.02.017
59. Ferro JM, Aguiar de Sousa D. Cerebral Venous Thrombosis: an Update. Curr Neurol Neurosci Rep. 2019;19(10):74. DOI:10.1007/s11910-019-0988-x
60. Triquenot Bagan A, Crassard I, Drouet L, et al. Cerebral Venous Thrombosis: Clinical, Radiological, Biological, and Etiological Characteristics of a French Prospective Cohort (FPCCVT)–Comparison with ISCVT Cohort. Front Neurol. 2021;12:753110. DOI:10.3389/fneur.2021.753110
61. Yaghi S, Shu L, Bakradze E, et al. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. Stroke. 2022;53(3):728-38. DOI:10.1161/STROKEAHA.121.037541
62. Green M, Styles T, Russell T, et al. Non-genetic and genetic risk factors for adult cerebral venous thrombosis. Thromb Res. 2018;169:15-22. DOI:10.1016/j.thromres.2018.07.005
________________________________________________
2. Amalia L. D-Dimer Level Associated with Amount of Sinus involvement Using Digital Subtraction Angiography on Cerebral Venous Thrombosis Patients. J Blood Med.
2023;14:303-8. DOI:10.2147/JBM.S399661
3. Theologou R, Nteveros A, Artemiadis A, Faropoulos K. Rare Causes of Cerebral Venus Sinus Thrombosis: A Systematic Review. Life. 2023;13(5):1178. DOI:10.3390/life13051178
4. Canedo-Antelo M, Baleato-González S, Mosqueira AJ, et al. Radiologic Clues to Cerebral Venous Thrombosis. Radiographics. 2019;39(6):1611-28. DOI:10.1148/rg.2019190015
5. Wei H, Jiang H, Zhou Y, et al. Intracranial hypertension after cerebral venous thrombosis–Risk factors and outcomes. CNS Neurosci Ther. 2023;29(9):2540-7. DOI:10.1111/cns.14194
6. Fan Y, Yu J, Chen H, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis. Stroke Vasc Neurol. 2020;5(2):152-8. DOI:10.1136/svn-2020-000358
7. Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555-65. DOI:10.1038/nrneurol.2017.104
8. Zenobia E, Lailiyya N, Dian S, et al. Platelet Selectin Levels in Patients with Cerebral Venous Sinus Thrombosis: Preliminary Findings. J Blood Med. 2023;14:359-65. DOI:10.2147/JBM.S405975
9. Sader N, de Lotbinière-Bassett M, Tso MK, Hamilton M. Management of Venous Sinus Thrombosis. Neurosurg Clin N Am. 2018;29(4):585-94. DOI:10.1016/j.nec.2018.06.011
10. Ulivi L, Squitieri M, Cohen H, et al. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020;20(5):356-67. DOI:10.1136/practneurol-2019-002415
11. Zuurbier SM, Hiltunen S, Tatlisumak T, et al. Admission Hyperglycemia and Clinical Outcome in Cerebral Venous Thrombosis. Stroke. 2016;47(2):390-6. DOI:10.1161/STROKEAHA.115.011177
12. Hung SH, Lin HC, Chung SD. Association between venous thromboembolism and iron-deficiency anemia: a population-based study. Blood Coagul Fibrinolysis.
2015;26(4):368-72. DOI:10.1097/MBC.0000000000000249
13. Liu K, Song B, Gao Y, et al. Long-Term Outcomes in Patients with Anemia And Cerebral Venous Thrombosis. Neurocrit Care. 2018;29(3):463-8. DOI:10.1007/s12028-018-0544-6
14. Azizi N, Maghbooli M, Rostami M, Kian S. Serum Levels of Ferritin, Iron, and TIBC in Cerebral Venous Sinus Thrombosis. Arch Neurosci. 2023;10(2). DOI:10.5812/ans-134857
15. Barboza MA, Mejias C, Colin-Luna J, et al. Intracranial venous collaterals in cerebral venous thrombosis: clinical and imaging impact. J Neurol Neurosurg Psychiatry. 2015;86(12):1314-8. DOI:10.1136/jnnp-2014-309717
16. Song S, Lan D, Wu XQ, Meng R. The clinical characteristic, diagnosis, treatment, and prognosis of cerebral cortical vein thrombosis: a systematic review of 325 cases. J Thromb Thrombolysis. 2021;51(3):734-40. DOI:10.1007/s11239-020-02229-x
17. Duman T, Uluduz D, Midi I, et al. A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study. J Stroke Cerebrovasc Dis.
2017;26(8):1848-57. DOI:10.1016/j.jstrokecerebrovasdis.2017.04.020
18. Lindgren E, Krzywicka K, de Winter MA, et al. A scoring tool to predict mortality and dependency after cerebral venous thrombosis. Eur J Neurol. 2023;30(8):2305-14.. DOI:10.1111/ene.15844
19. Begley SL, White TG, Katz JM. Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy. Curr Treat Options Neurol. 2023;25(8):1-17.
DOI:10.1007/s11940-023-00752-9
20. Huang P. Rare cause of cerebral venous sinus thrombosis: Spontaneous intracranial hypotension syndrome: A case report. World J Clin Cases. 2023;11(19):4677-83. DOI:10.12998/wjcc.v11.i19.4677
21. Chen YC, Chang CW, Wu HC, et al. Clinical Characteristics and Prognostic Factors of Non-Infectious Cerebral Venous Sinus Thrombosis. J Clin Med. 2022;11(20):6096. DOI:10.3390/jcm11206096
22. Pasricha SV, Bhayana R, Wu PE. Supine headache and papilledema: A case and review of cerebral venous sinus thrombosis. Clin Case Rep. 2023;11(5):e07329. DOI:10.1002/ccr3.7329
23. Pongmoragot J, Saposnik G. Intracerebral Hemorrhage from Cerebral Venous Thrombosis. Curr Atheroscler Rep. 2012;14(4):382-9. DOI:10.1007/s11883-012-0260-1
24. Coutinho JM, Zuurbier SM, Stam J. Declining Mortality in Cerebral Venous Thrombosis: A Systematic Review. Stroke. 2014;45(5):1338-41. DOI:10.1161/STROKEAHA.113.004666
25. Sachdeva V, Nalawade R, Kannam M, et al. Clinical profile, diagnostic challenges, and outcomes in subacute/chronic cerebral sinus venous thrombosis. Indian J Ophthalmol. 2021;69(12):3598. DOI:10.4103/ijo.IJO_96_21
26. Afifi K, Bellanger G, Buyck PJ, et al. Features of intracranial hemorrhage in cerebral venous thrombosis. J Neurol. 2020;267(11):3292-8. DOI:10.1007/s00415-020-10008-0
27. Kumral E, Polat F, Uzunköprü C, et al. The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non-hemorrhagic infarct, and non-lesional venous stroke in patients with cerebral sinus-venous thrombosis: The clinical/neuroradiological spectrum of cerebral sinus-vein thrombosis. Eur J Neurol. 2012;19(4):537-43. DOI:10.1111/j.1468-1331.2011.03562.x
28. Mahale R, Mehta A, John AA, et al. Acute seizures in cerebral venous sinus thrombosis: What predicts it? Epilepsy Res. 2016;123:1-5. DOI:10.1016/j.eplepsyres.2016.01.011
29. Uluduz D, Midi I, Duman T, et al. Epileptic seizures in cerebral venous sinus thrombosis: Subgroup analysis of VENOST study. Seizure. 2020;78:113-7. DOI:10.1016/j.seizure.2020.02.017
30. Ferro JM, Canhão P, Bousser MG, et al. Early Seizures in Cerebral Vein and Dural Sinus Thrombosis: Risk Factors and Role of Antiepileptics. Stroke.
2008;39(4):1152-8. DOI:10.1161/STROKEAHA.107.487363
31. García-Azorín D, Monje MHG, González-García N, et al. Presence of red flags in patients with cerebral venous sinus thrombosis admitted to the emergency department because of headache: A STROBE compliant cohort-study. Medicine (Baltimore). 2020;99(29):e20900. DOI:10.1097/MD.0000000000020900
32. Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – Endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195-221. DOI:10.1177/2396987317719364
33. Kharbat AF, Michel M, Morgan R, et al. Intracranial venous sinus thrombosis: Medical and surgical management considerations. BOHR Int J Neurol Neurosci.
2023;1(2):60-71. DOI:10.54646/bijnn.2023.09
34. Herweh C, Griebe M, Geisbüsch C, et al. Frequency and temporal profile of recanalization after cerebral vein and sinus thrombosis. Eur J Neurol. 2016;23(4):681-7. DOI:10.1111/ene.12901
35. Alimohammadi A, Kim DJ, Field TS. Updates in cerebral venous thrombosis. Curr Cardiol Rep. 2022;24(1):43-50. DOI:10.1007/s11886-021-01622-z
36. Wasay M, Khan M, Rajput HM, et al. New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study. J Stroke.
2019;21(2):220-3. DOI:10.5853/jos.2019.00150
37. Li H, Yao M, Liao S, et al. Comparison of Novel Oral Anticoagulants and Vitamin K Antagonists in Patients With Cerebral Venous Sinus Thrombosis on Efficacy and Safety: A Systematic Review. Front Neurol. 2020;11:597623. DOI:10.3389/fneur.2020.597623
38. Lee GKH, Chen VH, Tan CH, et al. Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis. J Thromb Thrombolysis. 2020;50(3):724-31. DOI:10.1007/s11239-020-02106-7
39. Nepal G, Kharel S, Bhagat R, et al. Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta-analysis. Acta Neurol Scand. 2022;145(1):10-23. DOI:10.1111/ane.13506
40. Esmaeili S, Abolmaali M, Aarabi S, et al. Rivaroxaban for the treatment of cerebral venous thrombosis. BMC Neurol. 2021;21(1):73. DOI:10.1186/s12883-021-02091-1
41. Maqsood M, Imran Hasan Khan M, Yameen M, et al. Use of oral rivaroxaban in cerebral venous thrombosis. J Drug Assess. 2021;10(1):1-6. DOI:10.1080/21556660.2020.1838769
42. Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis.
2019;78(10):1296-304. DOI:10.1136/annrheumdis-2019-215213
43. Dubey AK, Kalita J, Chaudhary SK, Misra UK. Impact of anticoagulation status on recanalization and outcome of cerebral venous thrombosis. J Clin Neurosci. 2021;89:43-50. DOI:10.1016/j.jocn.2021.04.016
44. Gazioglu S, Eyuboglu I, Yildirim A, et al. Cerebral venous sinus Thrombosis: Clinical Features, Long-Term outcome and recanalization. J Clin Neurosci. 2017;45:248-51. DOI:10.1016/j.jocn.2017.07.028
45. Zhao Y, Su X, Liu Z, et al. Effect of intracranial venous collaterals on neurological outcomes in cerebral venous thrombosis. J Clin Neurosci. 2022;102:95-100. DOI:10.1016/j.jocn.2022.06.009
46. Ferro JM, Canhão P, Stam J, et al. Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664-70. DOI:10.1161/01.STR.0000117571.76197.26
47. Ilyas A, Chen CJ, Raper DM, et al. Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: a systematic review. J NeuroInterventional Surg.
2017;9(11):1086-92. DOI:10.1136/neurintsurg-2016-012938
48. Klein P, Shu L, Nguyen TN, et al. Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score. J Stroke. 2022;24(3):404-16. DOI:10.5853/jos.2022.01606
49. Liu L, Jiang H, Wei H, et al. Risk factors of impaired employability after cerebral venous thrombosis. CNS Neurosci Ther. 2023;29(4):1086-93. DOI:10.1111/cns.14083
50. Rezoagli E, Martinelli I, Poli D, et al. The effect of recanalization on long-term neurological outcome after cerebral venous thrombosis. J Thromb Haemost. 2018;16(4):718-24. DOI:10.1111/jth.13954
51. Shakibajahromi B, Haghighi AB, Salehi A, et al. Clinical and radiological characteristics and predictors of outcome of cerebral venous sinus thrombosis, a hospital-based study. Acta Neurol Belg. 2020;120(4):845-52. DOI:10.1007/s13760-018-1009-6
52. Zhang Y, Liu Y, Qin B, et al. Characteristics of Poor Prognosis in Patients with Cerebral Venous Sinus Thrombosis: A Multicenter Retrospective Study. Neuropsychiatr Dis Treat. 2023;19:1417-26. DOI:10.2147/NDT.S414123
53. Aguiar de Sousa D, Lucas Neto L, Arauz A, et al. Early Recanalization in Patients With Cerebral Venous Thrombosis Treated With Anticoagulation. Stroke.
2020;51(4):1174-81. DOI:10.1161/STROKEAHA.119.028532
54. Aguiar de Sousa D, Lucas Neto L, Canhão P, Ferro JM. Recanalization in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis. Stroke.
2018;49(8):1828-35. DOI:10.1161/STROKEAHA.118.022129
55. Arauz A, Vargas-González JC, Arguelles-Morales N, et al. Time to recanalisation in patients with cerebral venous thrombosis under anticoagulation therapy. J Neurol Neurosurg Psychiatry. 2016;87(3):247-51. DOI:10.1136/jnnp-2014-310068
56. Karthik Vanukuri N, Pedapati R, Shanmugam S, et al. Effect of recanalization on clinical outcomes in patients with cerebral venous thrombosis – An ambispective study. Eur J Radiol. 2022;153:110385. DOI:10.1016/j.ejrad.2022.110385
57. Nagaraja D. Recanalisation and outcome in cerebral venous-sinus thrombosis. Ann Indian Acad Neurol. 2022;25(2):177. DOI:10.4103/aian.aian_957_21
58. Putaala J, Hiltunen S, Salonen O, et al. Recanalization and its correlation to outcome after cerebral venous thrombosis. J Neurol Sci. 2010;292(1-2):11-5. DOI:10.1016/j.jns.2010.02.017
59. Ferro JM, Aguiar de Sousa D. Cerebral Venous Thrombosis: an Update. Curr Neurol Neurosci Rep. 2019;19(10):74. DOI:10.1007/s11910-019-0988-x
60. Triquenot Bagan A, Crassard I, Drouet L, et al. Cerebral Venous Thrombosis: Clinical, Radiological, Biological, and Etiological Characteristics of a French Prospective Cohort (FPCCVT)–Comparison with ISCVT Cohort. Front Neurol. 2021;12:753110. DOI:10.3389/fneur.2021.753110
61. Yaghi S, Shu L, Bakradze E, et al. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. Stroke. 2022;53(3):728-38. DOI:10.1161/STROKEAHA.121.037541
62. Green M, Styles T, Russell T, et al. Non-genetic and genetic risk factors for adult cerebral venous thrombosis. Thromb Res. 2018;169:15-22. DOI:10.1016/j.thromres.2018.07.005
Авторы
Т.Ю. Батенькова*
ГАУЗ СО «Свердловская областная клиническая больница №1», Екатеринбург, Россия
*tuska-9494@yandex.ru
Sverdlovsk Regional Clinical Hospital №1, Yekaterinburg, Russia
*tuska-9494@yandex.ru
ГАУЗ СО «Свердловская областная клиническая больница №1», Екатеринбург, Россия
*tuska-9494@yandex.ru
________________________________________________
Sverdlovsk Regional Clinical Hospital №1, Yekaterinburg, Russia
*tuska-9494@yandex.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.